In Progress

May 27, 2025

CAVALIER Trial

The CAlcium and VAsopressin following Injury Early Resuscitation trial, or simply CAVALIER, is a research study that will look at whether giving calcium, vasopressin, or both early in the course of treatment would help severely injured patients that lose a lot of blood survive their injuries.

Normally when a person loses a lot of blood, they may receive calcium, vasopressin, or both as part of standard medical care, but not until they arrive at the hospital or are admitted to an intensive care unit (ICU). After a patient is determined to be sick enough to enroll in the study, researchers will do a randomization (like flipping a coin) to determine if the patient will receive a study drug or a placebo (salt water).

Investigator

Role

Project(s)

Joseph Margolick, MD

PI

Task Order 010 (CAVALIER)

Brian Russ, MD

PI

 

Brandon Morshedi, MD

Co-I

Task Order 010 (CAVALIER)

Matthew Roberts, MD

Co-I

Task Order 010 (CAVALIER)

Dynamic Content Image

CONTACTS

Dynamic Content Image

Garrett Whisenhunt

Clinical Coodinator

Robert.Whisenhunt@metroems.org

Dr. Brandon Morshedi

Chief Medical Officer

LINKS AND DOWNLOADS

BILLING QUESTIONS

MEMS is committed to providing quick and accurate responses to your inquiries about your billing statement or any other questions that you might have regarding your bill. Please contact our billing office, Monday to Friday, from 8am to 5pm at 501.301.1403.

WHAT IS HIPAA?

HIPAA (Health Insurance Portability and Accountability Act of 1996) is United States legislation that provides data privacy and security provisions for safeguarding medical information.
LEARN MORE
We Value Your Privacy

We use cookies to enhance your experience. By clicking "Accept," you agree to our use of cookies. You can manage your preferences anytime.